Non-Invasive Aesthetic Treatments Market By Procedure (Injectables, Skin Rejuvenation, Others), By End-use (Hospital/Surgery Center, Medspa, Traditional Spa, HCP owned Clinic), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
- Published date: Apr 2024
- Report ID: 117852
- Number of Pages:
- Format:
-
Quick Navigation
Report Overview
The Global Non-Invasive Aesthetic Treatments Market size is expected to be worth around USD 304.4 Billion by 2033, from USD 70.8 Billion in 2023, growing at a CAGR of 15.7% during the forecast period from 2024 to 2033.
The non-invasive aesthetic treatments market is a rapidly growing sector within the healthcare and beauty industry, driven by the increasing demand for cosmetic procedures that do not require surgery. These treatments focus on enhancing physical appearance, addressing aging signs, and improving skin texture without invasive surgical procedures.
One of the primary drivers of this market is the growing emphasis on aesthetics and beauty standards globally, fueled by social media influence, celebrity endorsements, and the desire for youthful appearance. Additionally, technological advancements in non-invasive procedures, such as laser therapies, radiofrequency treatments, injectables like Botox and dermal fillers, and non-surgical body contouring techniques, have contributed to the market’s growth.
Furthermore, the rising disposable income levels, especially in emerging economies, have made non-invasive aesthetic treatments more accessible to a wider population. Moreover, the aging population seeking non-surgical solutions for skin rejuvenation and anti-aging benefits has further propelled market growth.
Key players in the non-invasive aesthetic treatments market include medical spas, cosmetic clinics, dermatology practices, and aesthetic centers. These providers offer a range of services, from facial treatments to body sculpting procedures, catering to diverse consumer preferences. However, challenges such as regulatory requirements, safety concerns, and pricing pressures may impact market dynamics.
Nevertheless, the market is expected to continue its upward trajectory, driven by advancements in technology, expanding consumer awareness, and the growing acceptance of non-invasive aesthetic treatments as effective alternatives to traditional surgical procedures.
- According to the American Society of Plastic Surgeons, there has been a notable 19% increase in cosmetic surgery procedures since 2019.
- According to a report published by the International Society of Aesthetic Plastic Surgery (ISAPS), there were 18.8 million non-surgical procedures performed on a global scale.
Key Takeaways
- The market for non-invasive aesthetic treatment generated a revenue of USD 70.8 billion in 2023, and is poised to reach USD 304.4 billion by the year 2033, with a CAGR of 15.7%.
- The non-invasive aesthetic treatments market worldwide is segmented based on procedures, which include injectable treatments, skin rejuvenation procedures, and other treatments.
- In 2023, the injectable segment stood out as the market leader, representing more than 64.7% of the total revenue share.
- Additionally, the market is categorized by end uses, such as hospital/surgery centers, MedSpa facilities, traditional spas, and clinics owned by healthcare professionals (HCPs). Among these categories, MedSpa facilities emerged as the largest contributor, accounting for over 36.2% of the global revenue in 2023.
- In terms of regional dominance, North America held a significant position in the global non-invasive aesthetic treatments market in 2023, capturing a substantial share of over 38.0% of the total revenue.
Procedure Analysis
The global market for non-invasive aesthetic treatments is segmented based on procedures, including injectable, skin rejuvenation, and others. Among these, the injectable segment dominated the market in 2023, accounting for over 64.7% of revenue share. This segment is projected to maintain its leading position, exhibiting the fastest compound annual growth rate (CAGR) during the forecast period. Injectables are favored by surgeons for their ease of use, faster treatment delivery, quick results, and minimal downtime compared to other procedures.
The others segment comprises various treatments such as hair removal, non-surgical fat reduction, sclerotherapy, and cellulite treatments. Non-surgical fat reduction is anticipated to experience the fastest CAGR in this segment over the forecast period. Laser hair removal is also witnessing increased adoption due to its cost-effectiveness and time-saving benefits compared to traditional hair removal methods like waxing, shaving, or using hair removal creams. These trends reflect evolving consumer preferences and the growing demand for efficient and convenient non-invasive aesthetic procedures across different segments of the market.
End-Use Analysis
The global market for non-invasive aesthetic treatments is categorized by end uses into hospital/surgery centers, MedSpa, traditional spa, and HCP-owned clinics. Among these, the medspa segment emerged as the largest contributor, accounting for over 36.2% of global revenue in 2023. This segment is anticipated to maintain its dominance and experience the fastest compound annual growth rate (CAGR) throughout the forecast period.
Medspa facilities are specialized establishments where cosmetic services are offered under the supervision of licensed physicians. These facilities focus on providing non-invasive treatments such as facial injections, non-invasive body contouring, skin rejuvenation, and laser treatments, all administered by experienced professionals.
The popularity of medspas can be attributed to their comprehensive services, skilled staff, and the trust they instill in patients seeking aesthetic enhancements without invasive procedures. The projected expansion and continued dominance of the medspa segment underscore the growing preference for non-invasive aesthetic procedures and the importance of professional supervision and expertise in delivering satisfactory outcomes for patients globally.
Key Market Segments
By Procedure
- Injectables
- Botulinum Toxin
- Calcium Hydroxylapatite
- Hyaluronic Acid
- Polymer Filler
- Collagen
- Skin Rejuvenation
- Chemical Peel
- Laser Skin Resurfacing
- Photorejuvenation
- Others
- Hair Removal
- Nonsurgical Fat Reduction
- Sclerotherapy
- Cellulite Treatment
By End-use
- Hospital/Surgery Center
- Medspa
- Traditional Spa
- HCP owned clinic
Market Drivers
Increasing Demand for Aesthetic Procedures
One of the primary drivers of the non-invasive aesthetic treatments market is the growing demand for aesthetic procedures globally. Factors such as social media influence, celebrity endorsements, and changing beauty standards have significantly contributed to the rising popularity of non-invasive treatments. Consumers, both men and women, are increasingly seeking ways to enhance their appearance, address aging signs, and improve their self-confidence through aesthetic procedures.
Technological Advancements
Advancements in technology play a crucial role in driving the non-invasive aesthetic treatments market. Innovations in laser technologies, radiofrequency devices, ultrasound treatments, and other non-surgical techniques have revolutionized the field of aesthetic medicine. These technological advancements have led to safer, more effective, and minimally invasive procedures, attracting a larger pool of patients seeking cosmetic enhancements.
Rising Disposable Income
Increasing disposable income levels, especially in emerging economies, have made non-invasive aesthetic treatments more accessible to a broader segment of the population. As people have more financial resources, they are willing to invest in cosmetic procedures to improve their appearance and overall well-being. This trend has led to a surge in demand for non-invasive treatments, driving market growth.
Restraints
Regulatory Compliance and Safety Concerns
One of the significant restraints in the non-invasive aesthetic treatments market is regulatory compliance and safety concerns. Regulatory bodies impose strict guidelines and standards for the use of medical devices, cosmetic products, and treatment procedures to ensure patient safety and efficacy.
Compliance with these regulations requires healthcare providers, aesthetic centers, and manufacturers to invest in quality assurance, training, and certification programs. Failure to comply with regulatory requirements can lead to legal consequences, product recalls, and damage to reputation, affecting market growth.
Cost and Affordability
Cost considerations and affordability are significant restraints for many patients considering non-invasive aesthetic treatments. While these procedures may be less expensive than surgical alternatives, they still incur costs that may be prohibitive for some individuals. Factors such as treatment fees, maintenance sessions, post-procedure care, and associated expenses can add up, limiting accessibility to a broader demographic. Affordable financing options, insurance coverage for certain procedures, and competitive pricing strategies can help mitigate this restraint.
Opportunities
There is a notable increase in the demand for non-invasive aesthetic treatments among younger demographics, including millennials and Generation Z. This demographic cohort places a strong emphasis on self-care, appearance enhancement, and preventive aesthetics, driving demand for treatments such as skin rejuvenation, injectables, and body contouring at earlier stages.
Continued advancements in technology, such as advanced laser therapies, energy-based devices, and novel treatment modalities, offer significant opportunities for the market. These innovations enhance treatment efficacy, safety, and patient experience, attracting a larger consumer base and expanding the scope of non-invasive procedures.
Furthermore, the market’s expansion into emerging markets and untapped regions presents lucrative opportunities for growth. Rising disposable incomes, changing beauty standards, and increasing awareness about aesthetic treatments in regions such as Asia-Pacific, Latin America, and the Middle East offer a fertile ground for market penetration and business expansion.
Impact of Macroeconomic / Geopolitical Factors
Government policies, interest rates, taxes, and other macroeconomic factors can significantly impact the non-invasive aesthetic treatments market. Favorable government policies that promote healthcare access and affordability, support research and development, and regulate safety standards can stimulate market growth.
Changes in interest rates can influence consumer spending behavior, affecting demand for aesthetic treatments. Tax policies may impact the cost of procedures for both providers and consumers, influencing market competitiveness and pricing strategies.
Additionally, economic conditions such as GDP growth, inflation rates, and employment levels can affect disposable income and consumer confidence, ultimately shaping the demand for non-invasive aesthetic treatments. Overall, a stable and supportive macroeconomic environment tends to foster growth in the market, while fluctuations or unfavorable policies can pose challenges to industry expansion.
Latest Trends
The non-invasive aesthetic treatments market is witnessing several latest trends that are shaping its trajectory and influencing consumer preferences. One prominent trend is the rise of combination therapies and integrative approaches, where providers offer a blend of treatments such as injectables, skin rejuvenation, and body contouring alongside wellness programs and nutritional counseling for comprehensive results.
Personalization and customization are also gaining traction, with patients seeking tailored treatment plans based on their unique needs and aesthetic goals. Additionally, there is a growing demand for minimally invasive procedures that offer natural-looking results, minimal downtime, and long-lasting outcomes.
Technological advancements, particularly in energy-based devices and advanced laser therapies, are driving innovation and expanding the scope of non-invasive treatments, while partnerships between aesthetic centers, healthcare providers, and beauty brands are fostering collaborative solutions and enhancing the overall patient experience.
Regional Analysis
North America is leading the Non-Invasive Aesthetic Treatments Market
North America maintained its position as the leader in the global non-invasive aesthetic treatment market in 2023, securing more than 38.0% of the total revenue share. This continued dominance is attributed to the increasing demand for cosmetic procedures in the region. The population’s growing interest in non-invasive aesthetic treatments, coupled with advancements in technology and techniques, has fueled the demand for such services across North America.
Additionally, factors such as higher disposable income levels, greater awareness about aesthetic enhancements, and the presence of a well-established healthcare infrastructure contribute to the region’s leading position in the non-invasive aesthetic treatment market.
The Asia Pacific region is expected to experience the highest CAGR during the forecast period
Meanwhile, Asia Pacific is poised for rapid growth, projected at over 17.4% during the forecast period. Countries like China, India, and Thailand are driving this expansion, fueled by heightened consumer awareness of physical appearance, especially in emerging markets like Thailand, expected to exhibit the fastest growth among all nations.
Key Regions and Countries
- North America
- US
- Canada
- Europe
- Germany
- France
- The UK
- Spain
- Italy
- Russia
- Netherland
- Rest of Europe
- Asia Pacific
- China
- Japan
- South Korea
- India
- New Zealand
- Singapore
- Thailand
- Vietnam
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Rest of MEA
Key Players Analysis
The global non-invasive aesthetic treatment market is characterized by intense competition, driven by the presence of numerous global companies. Key players in the industry are actively pursuing growth strategies to strengthen their market positions and increase their market shares. These strategies include continuous enhancements in existing technologies to improve treatment efficacy and patient experience.
Geographical expansions are also a focus, with companies targeting new regions and markets to tap into emerging opportunities and expand their customer base. Product launches and approvals play a crucial role in staying competitive, as companies strive to introduce innovative treatments and secure regulatory approvals to ensure product quality and safety.
Overall, these growth strategies reflect the dynamic nature of the market and the ongoing efforts of key players to innovate, expand, and maintain their competitive edge in the global non-invasive aesthetic treatment market.
Top Key Players in Non-Invasive Aesthetic Treatments Market
- Hologic Inc.
- Allergan Inc.
- Galderma S.A.
- Alma Lasers
- Syneron Candela
- Johnson & Johnson
- MerzPharma
- Lumenis
- Solta Medical
- Cutera Inc.
- Revance Therapeutics Inc.
- Other Key Players
Recent Developments
- In January 2023, Lumos Diagnostics Holdings Ltd. has recently announced the signing of two significant agreements with Hologic Inc. These agreements include a Development Agreement and an Intellectual Property (IP) Agreement.
- In March 2024, Galderma Group AG, a skincare business, is planning to raise approximately $2.3 billion in what is anticipated to be one of the largest listings in Europe this year. This move serves as a significant test for the initial public offering (IPO) market in the region, indicating investor sentiment and market appetite for new offerings.
Report Scope
Report Features Description Market Value (2023) USD 70.8 billion Forecast Revenue (2033) USD 304.4 billion CAGR (2024-2033) 15.7% Base Year for Estimation 2023 Historic Period 2019-2022 Forecast Period 2024-2033 Report Coverage Revenue Forecast, Market Dynamics, COVID-19 Impact, Competitive Landscape, Recent Developments Segments Covered By Procedure – Injectables, Skin Rejuvenation, Others; By End-use – Hospital/Surgery Center, Medspa, Traditional Spa, HCP owned clinic Regional Analysis North America – US, Canada; Europe – Germany, France, The UK, Spain, Italy, Russia, Netherlands, Rest of Europe; Asia Pacific – China, Japan, South Korea, India, New Zealand, Singapore, Thailand, Vietnam, Rest of APAC; Latin America – Brazil, Mexico, Rest of Latin America; Middle East & Africa – South Africa, Saudi Arabia, UAE, Rest of MEA Competitive Landscape Hologic Inc., Allergan Inc., Galderma S.A., Alma Lasers, Syneron Candela, Johnson & Johnson, MerzPharma, Lumenis, Solta Medical, Cutera Inc., Revance Therapeutics Inc., and Other Key Players Customization Scope Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements. Purchase Options We have three licenses to opt for: Single User License, Multi-User License (Up to 5 Users), Corporate Use License (Unlimited User and Printable PDF) Non-Invasive Aesthetic Treatments MarketPublished date: Apr 2024add_shopping_cartBuy Now get_appDownload Sample -
-
- Hologic Inc.
- Allergan Inc.
- Galderma S.A.
- Alma Lasers
- Syneron Candela
- Johnson & Johnson
- MerzPharma
- Lumenis
- Solta Medical
- Cutera Inc.
- Revance Therapeutics Inc.
- Other Key Players
- settingsSettings
Our Clients
Single User
$6,000
$3,999
USD / per unit
save 24%
|
Multi User
$8,000
$5,999
USD / per unit
save 28%
|
Corporate User
$10,000
$6,999
USD / per unit
save 32%
|
|
---|---|---|---|
e-Access | |||
Report Library Access | |||
Data Set (Excel) | |||
Company Profile Library Access | |||
Interactive Dashboard | |||
Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
Accessibility | 1 User | 2-5 User | Unlimited |
Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
Buy Now ($ 3,999) | Buy Now ($ 5,999) | Buy Now ($ 6,999) |